Home
EWTX
EWTX News

Latest Edgewise Therapeutics Inc. (EWTX) News on July 27, 2024

‘Don’t Be Scared of Heights’: J.P. Morgan Suggests 2 Stocks to Buy

TipRanks

5 days ago

‘Don’t Be Scared of Heights’: J.P. Morgan Suggests 2 Stocks to Buy

Here's Why Edgewise Therapeutics, Inc. (EWTX) is a Great Momentum Stock to Buy

Zacks

9 days ago

Here's Why Edgewise Therapeutics, Inc. (EWTX) is a Great Momentum Stock to Buy

Three Surprising Names That Could Be On Biogen's Buyout Shortlist

Investor's Business Daily

10 days ago

Three Surprising Names That Could Be On Biogen's Buyout Shortlist

MT Newswires

17 days ago

Top Midday Gainers

MT Newswires

17 days ago

JPMorgan Raises Price Target on Edgewise Therapeutics to $30 From $27, Maintains Overweight Rating

GuruFocus.com

3 months ago

Edgewise Therapeutics Inc (EWTX) Reports First Quarter 2024 Financial Results

Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024

Business Wire

3 months ago

Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024

MT Newswires

3 months ago

Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating

Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Business Wire

3 months ago

Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Edgewise Therapeutics Appoints Arlene Morris to its Board of Directors

Business Wire

3 months ago

Edgewise Therapeutics Appoints Arlene Morris to its Board of Directors

Edgewise Therapeutics doses first subject in HCM drug trial

Clinical Trials Arena

3 months ago

Edgewise Therapeutics doses first subject in HCM drug trial

MT Newswires

3 months ago

Edgewise Therapeutics Says First Patient Dosed in Phase 2 Hypertrophic Cardiomyopathy Trial

Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)

Business Wire

3 months ago

Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)

MT Newswires

3 months ago

Edgewise Therapeutics Secures Orphan Drug Designations for Sevasemten in EU

Edgewise Receives European Medicines Agency (EMA) Orphan Drug Designations for Sevasemten (EDG-5506) for the Treatment of Becker and Duchenne Muscular Dystrophies

Business Wire

3 months ago

Edgewise Receives European Medicines Agency (EMA) Orphan Drug Designations for Sevasemten (EDG-5506) for the Treatment of Becker and Duchenne Muscular Dystrophies

Edgewise Therapeutics Announces Positive Two-Year Topline Results from the ARCH Open Label Trial of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy (Becker)

Business Wire

3 months ago

Edgewise Therapeutics Announces Positive Two-Year Topline Results from the ARCH Open Label Trial of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy (Becker)

Edgewise Therapeutics Announces Upcoming Podium Presentation at the American College of Cardiology's 2024 Annual Scientific Session

Business Wire

4 months ago

Edgewise Therapeutics Announces Upcoming Podium Presentation at the American College of Cardiology's 2024 Annual Scientific Session

Edgewise Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium on April 2, 2024

Business Wire

4 months ago

Edgewise Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium on April 2, 2024

Edgewise Therapeutics to Present at the Leerink Partners Global Biopharma Conference on March 11, 2024

Business Wire

5 months ago

Edgewise Therapeutics to Present at the Leerink Partners Global Biopharma Conference on March 11, 2024

Edgewise Therapeutics to Present on EDG-5506 for the Treatment of Becker Muscular Dystrophy at the 2024 MDA Clinical and Scientific Conference

Business Wire

5 months ago

Edgewise Therapeutics to Present on EDG-5506 for the Treatment of Becker Muscular Dystrophy at the 2024 MDA Clinical and Scientific Conference

Wall Street Analysts Predict a 52.78% Upside in Edgewise Therapeutics, Inc. (EWTX): Here's What You Should Know

Zacks

5 months ago

Wall Street Analysts Predict a 52.78% Upside in Edgewise Therapeutics, Inc. (EWTX): Here's What You Should Know

Edgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Business Wire

5 months ago

Edgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

13 Best Booming Stocks to Buy Right Now

Insider Monkey

5 months ago

13 Best Booming Stocks to Buy Right Now

Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne)

Business Wire

5 months ago

Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne)

Insider Favorites: 7 Stocks with Bullish Buying Signals

InvestorPlace

5 months ago

Insider Favorites: 7 Stocks with Bullish Buying Signals

Wall Street Analysts See a 33.27% Upside in Edgewise Therapeutics, Inc. (EWTX): Can the Stock Really Move This High?

Zacks

6 months ago

Wall Street Analysts See a 33.27% Upside in Edgewise Therapeutics, Inc. (EWTX): Can the Stock Really Move This High?

Reasons to Invest in Collegium Pharmaceutical (COLL)

Insider Monkey

6 months ago

Reasons to Invest in Collegium Pharmaceutical (COLL)

SRH Total Return Fund, Inc. Section 19(a) Notice

ACCESSWIRE

6 months ago

SRH Total Return Fund, Inc. Section 19(a) Notice

Director ZERBE ROBERT L MD Sells Shares of Vericel Corp (VCEL)

GuruFocus.com

6 months ago

Director ZERBE ROBERT L MD Sells Shares of Vericel Corp (VCEL)

These Stocks Are Moving the Most Today: SoFi, iRobot, McGrath RentCorp, ZoomInfo, Microsoft, Apple, and More

Barrons.com

6 months ago

These Stocks Are Moving the Most Today: SoFi, iRobot, McGrath RentCorp, ZoomInfo, Microsoft, Apple, and More

Edgewise Therapeutics Inc CFO R Carruthers Sells 90,000 Shares

GuruFocus.com

6 months ago

Edgewise Therapeutics Inc CFO R Carruthers Sells 90,000 Shares

Diebold Nixdorf to Conduct 2023 Fourth Quarter, Full-Year Investor Call on Feb. 14

PR Newswire

6 months ago

Diebold Nixdorf to Conduct 2023 Fourth Quarter, Full-Year Investor Call on Feb. 14

Why Collegium Pharmaceutical (COLL) Could Beat Earnings Estimates Again

Zacks

6 months ago

Why Collegium Pharmaceutical (COLL) Could Beat Earnings Estimates Again

Wall Street Analysts Think Edgewise Therapeutics, Inc. (EWTX) Could Surge 70.76%: Read This Before Placing a Bet

Zacks

6 months ago

Wall Street Analysts Think Edgewise Therapeutics, Inc. (EWTX) Could Surge 70.76%: Read This Before Placing a Bet

Tuya Smart Delivers IoT Best Practice Using Amazon Aurora, Leads the Direction of Cloud Database Innovation Use Cases with Amazon Web Services

PR Newswire

6 months ago

Tuya Smart Delivers IoT Best Practice Using Amazon Aurora, Leads the Direction of Cloud Database Innovation Use Cases with Amazon Web Services

Banner Corporation (NASDAQ:BANR) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Banner Corporation (NASDAQ:BANR) Q4 2023 Earnings Call Transcript

Business Wire

6 months ago

First Trust Intermediate Duration Preferred & Income Fund Declares its Monthly Common Share Distribution of $0.1375 Per Share for February

PDF Solutions to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 15, 2024

GlobeNewswire

6 months ago

PDF Solutions to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 15, 2024

Edgewise (EWTX) Rallies 35% on Issue of New Common Stock

Zacks

6 months ago

Edgewise (EWTX) Rallies 35% on Issue of New Common Stock

People Think Peloton Makes Money Selling Exercise Equipment, But 70% of Its Revenue Comes From Something Else Entirely

Motley Fool

6 months ago

People Think Peloton Makes Money Selling Exercise Equipment, But 70% of Its Revenue Comes From Something Else Entirely

Kaman (KAMN) Soars 100.9%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Kaman (KAMN) Soars 100.9%: Is Further Upside Left in the Stock?

Pliant Therapeutics Inc CFO Keith Cummings Sells 9,781 Shares

GuruFocus.com

6 months ago

Pliant Therapeutics Inc CFO Keith Cummings Sells 9,781 Shares

Edgewise Therapeutics Announces Pricing of $240 Million Underwritten Offering of Common Stock

Business Wire

6 months ago

Edgewise Therapeutics Announces Pricing of $240 Million Underwritten Offering of Common Stock

Leslie’s, Inc. to Report First Quarter Fiscal 2024 Financial Results on February 1, 2024

GlobeNewswire

6 months ago

Leslie’s, Inc. to Report First Quarter Fiscal 2024 Financial Results on February 1, 2024

Small-Cap Surprises: 7 Undiscovered Growth Stocks Poised to Explode

InvestorPlace

6 months ago

Small-Cap Surprises: 7 Undiscovered Growth Stocks Poised to Explode

Janus (JBI) Boosts Trojan Storage Security With Noke Smart Locks

Zacks

6 months ago

Janus (JBI) Boosts Trojan Storage Security With Noke Smart Locks

HTLF Schedules Fourth Quarter Earnings Conference Call for January 29, 2024

GlobeNewswire

6 months ago

HTLF Schedules Fourth Quarter Earnings Conference Call for January 29, 2024

Earnings Preview: First Busey (BUSE) Q4 Earnings Expected to Decline

Zacks

6 months ago

Earnings Preview: First Busey (BUSE) Q4 Earnings Expected to Decline

3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street

Motley Fool

6 months ago

3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street

ePlus Welcomes New Class of GRIT -- Girls Re-Imagining Tomorrow -- Participants

PR Newswire

6 months ago

ePlus Welcomes New Class of GRIT -- Girls Re-Imagining Tomorrow -- Participants

Should You Hold The Buckle (BKE)?

Insider Monkey

6 months ago

Should You Hold The Buckle (BKE)?

OneSpaWorld (OSW) Reports Q4 Business Update, Sales Up Y/Y

Zacks

7 months ago

OneSpaWorld (OSW) Reports Q4 Business Update, Sales Up Y/Y

Edgewise Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

7 months ago

Edgewise Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference

Zuora’s CFO to Participate in the 26th Annual Needham Growth Conference

Business Wire

7 months ago

Zuora’s CFO to Participate in the 26th Annual Needham Growth Conference

Business Wire

7 months ago

OneSpaWorld Announces Preliminary Fourth Quarter and Fiscal Year 2023 Revenue and EBITDA in line with Guidance and Introduces Fiscal 2024 Revenue and EBITDA Guidance

Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance

Business Wire

7 months ago

Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance

Kforce Inc.'s (NASDAQ:KFRC) Stock Been Rising: Are Strong Financials Guiding The Market?

Simply Wall St.

7 months ago

Kforce Inc.'s (NASDAQ:KFRC) Stock Been Rising: Are Strong Financials Guiding The Market?

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Zacks

7 months ago

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Business Wire

7 months ago

OneSpaWorld to Present at the 26th Annual ICR Conference

Edgewise Therapeutics Inc Director Jonathan Fox Acquires 10,857 Shares

GuruFocus.com

7 months ago

Edgewise Therapeutics Inc Director Jonathan Fox Acquires 10,857 Shares

12 Best Solar Power Stocks To Invest In According to Financial Media

Insider Monkey

7 months ago

12 Best Solar Power Stocks To Invest In According to Financial Media

Is Cracker Barrel (CBRL) Doomed to Have a Terrible 2024 Too?

Zacks

7 months ago

Is Cracker Barrel (CBRL) Doomed to Have a Terrible 2024 Too?

OneSpaWorld (OSW) Just Flashed Golden Cross Signal: Do You Buy?

Zacks

7 months ago

OneSpaWorld (OSW) Just Flashed Golden Cross Signal: Do You Buy?

We Think Edgewise Therapeutics (NASDAQ:EWTX) Can Afford To Drive Business Growth

Simply Wall St.

7 months ago

We Think Edgewise Therapeutics (NASDAQ:EWTX) Can Afford To Drive Business Growth

Enerpac Tool Group Corp. (NYSE:EPAC) Q1 2024 Earnings Call Transcript

Insider Monkey

7 months ago

Enerpac Tool Group Corp. (NYSE:EPAC) Q1 2024 Earnings Call Transcript

First Trust Intermediate Duration Preferred & Income Fund Declares its Monthly Common Share Distribution of $0.1375 Per Share for January

Business Wire

7 months ago

First Trust Intermediate Duration Preferred & Income Fund Declares its Monthly Common Share Distribution of $0.1375 Per Share for January

The Price Is Right For Antero Midstream Corporation (NYSE:AM)

Simply Wall St.

7 months ago

The Price Is Right For Antero Midstream Corporation (NYSE:AM)

Insider Sell: CFO William Zerella Sells 17,500 Shares of ACV Auctions Inc (ACVA)

GuruFocus.com

7 months ago

Insider Sell: CFO William Zerella Sells 17,500 Shares of ACV Auctions Inc (ACVA)

Growth Stocks Under $50 for December 2023

Investopedia

7 months ago

Growth Stocks Under $50 for December 2023

Insider Sell: Kforce Inc's COO David Kelly Sells 5,000 Shares

GuruFocus.com

7 months ago

Insider Sell: Kforce Inc's COO David Kelly Sells 5,000 Shares

Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China’s National Reimbursement Drug List

Business Wire

7 months ago

Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China’s National Reimbursement Drug List

Why Cassava Sciences Stock Soared Today

Motley Fool

8 months ago

Why Cassava Sciences Stock Soared Today

Bright Horizons Stock Shines Amid Return-To-Office Work Paradigm

Investor's Business Daily

8 months ago

Bright Horizons Stock Shines Amid Return-To-Office Work Paradigm

National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12

Simply Wall St.

8 months ago

National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12

New Mountain Finance Corporation Appoints Kris Corbett as Chief Financial Officer

Business Wire

8 months ago

New Mountain Finance Corporation Appoints Kris Corbett as Chief Financial Officer

GlobeNewswire

8 months ago

Formula Systems Reports Third Quarter and Nine Months 2023 Financial Results:

Docebo Inc.'s (TSE:DCBO) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Simply Wall St.

8 months ago

Docebo Inc.'s (TSE:DCBO) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

National Research Corporation Declares Quarterly Dividend

GlobeNewswire

8 months ago

National Research Corporation Declares Quarterly Dividend

3 Cutting-Edge Biotech Stocks for the Bold Investor

InvestorPlace

8 months ago

3 Cutting-Edge Biotech Stocks for the Bold Investor

Central Puerto announces Results for the Quarter and Nine-Month Period Ended on September 30, 2023

ACCESSWIRE

8 months ago

Central Puerto announces Results for the Quarter and Nine-Month Period Ended on September 30, 2023

Business Wire

9 months ago

Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook

Does Addus HomeCare (ADUS) Have the Potential to Rally 33.85% as Wall Street Analysts Expect?

Zacks

9 months ago

Does Addus HomeCare (ADUS) Have the Potential to Rally 33.85% as Wall Street Analysts Expect?

Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services

Business Wire

9 months ago

Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services

Enerplus Announces December Quarterly Dividend

Hart Energy

9 months ago

Enerplus Announces December Quarterly Dividend

Claros Mortgage Trust, Inc. (NYSE:CMTG) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Claros Mortgage Trust, Inc. (NYSE:CMTG) Q3 2023 Earnings Call Transcript

Share on Social Networks: